Share this article

Cancer care specialist community Tennessee Oncology has joined Targeted Oncology’s strategic alliance partnership (SAP) programme.

Targeted Oncology is a multimedia resource that offers content and expert opinions on emerging therapeutics in the field of oncology.

Targeted Oncology parent company MJH Life Sciences president and CEO Mike Hennessy said: “We are so excited to be partnering with Tennessee Oncology.

“They are one of the premier oncology specialty groups in the country, and we look forward to helping them disseminate information to improve cancer care for patients and their families.”

Under the SAP programme, Targeted Oncology has partnered with leading national oncology associations, state oncology societies, and community cancer centres to bring oncologists the most important news in research and best treatment practices for cancer.

The SAP programme is aimed at creating a community of advocacy groups, medical associations and medical institutions to provide an open exchange of information for overall patient care.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Targeted Oncology will work with Tennessee Oncology to share exclusive information, as part of this joint effort.

Tennessee Oncology said in a press statement: “Our longstanding mission is to provide the highest quality cancer care and access to cutting edge treatments for patients close to home.

“Our partnership with Targeted Oncology is perfectly aligned with this mission by improving provider access to continued education about the newest advancements in the delivery of personalised medicine, and then sharing these learnings across our network of over 70 oncologists caring for patients in the local communities where our patients live.”